Metabolic Research
RetatrutideRetatrutide is a peptide that activates GIP, GLP-1 and glucagon receptors, studied in human trials of obesity and type 2 diabetes.
₹3,2001 vial
Explore the metabolic research collection. Compare strengths and current availability.
2 compounds · Prices in INR
Retatrutide is a peptide that activates GIP, GLP-1 and glucagon receptors, studied in human trials of obesity and type 2 diabetes.
Tirzepatide (LY3298176) is a synthetic peptide studied for its activity at GIP and GLP-1 receptors and its role in incretin signalling.
Research categories organise the catalogue and do not imply effects in people.
Review the selected strength, confirmed identity, packaging unit and available batch documentation.